tiprankstipranks
Trending News
More News >

Noronex Director Adjusts Investment Portfolio

Story Highlights
Noronex Director Adjusts Investment Portfolio

The latest update is out from Noronex Ltd. ( (AU:NRX) ).

Noronex Limited has announced a change in the interests of its director, Robert Klug, involving the acquisition of 1,000,000 ordinary shares and the disposal of 1,000,000 unquoted options. This transaction results in Mr. Klug holding a total of 2,000,000 ordinary shares and 100,000 quoted options. The exercise of unquoted options was valued at $14,000, indicating a strategic adjustment in the director’s investment portfolio, which could reflect confidence in the company’s future performance.

More about Noronex Ltd.

YTD Price Performance: 72.73%

Average Trading Volume: 1,568,553

Technical Sentiment Signal: Sell

Current Market Cap: A$9.66M

For a thorough assessment of NRX stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App